Hong Kong government to delay imports of AstraZeneca vaccine amid safety concerns

Hong Kong government to delay imports of AstraZeneca vaccine amid safety concerns

HONG KONG, April 9 (Reuters) - Hong Kong said on Friday it will delay shipments of AstraZeneca’s COVID-19 vaccine this year amid mounting concerns over possible links between the shot and very rare cases of blood clots. The Chinese-ruled city had ordered 7.5 million doses from the British-Swedish company, which were scheduled to arrive in the second half of 2021. Health Secretary Sophia Chan said the global financial centre had a sufficient supply of vaccines, with a total of 15 million doses of Germany’s BioNTech and China’s Sinovac - the only two vaccines available in the city. “Even if we have signed a pre-purchase agreement with AstraZeneca, we believe that AstraZeneca vaccines will not need to be supplied to Hong Kong this year, so as not to cause a waste when the vaccine is still in short supply globally, ” Chan said. The government was considering buying a new type of vaccine that may offer better protection, she added. More than 700,000 COVID-19 vaccine doses have been administered to the city’s 7.5 million population so far, a figure Hong Kong …
More on: www.thestar.com.my